Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Infinity Pharmaceuticals, Inc.

News headline image
Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI MEIP
News headline image
Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Reports Full Year 2022 Financial Results
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Announces the Date of Its Second Quarter 2022 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Announces the Date of Its First Quarter 2022 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Company Highlights
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Announces the Date of Its Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals to Be Featured in a Fireside Chat as Part of B. Riley’s 2022 Virtual Oncology Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity to Present at 40th Annual J.P. Morgan Healthcare Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy and Provides 2022 Guidance
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Added to the NASDAQ Biotechnology Index
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals to be Featured in B. Riley Fireside Chat
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Encouraging Updated Data from Phase 2 MARIO-3 TNBC Trial Presented at 2021 San Antonio Breast Cancer Symposium
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals to Host an Investor Event on Updated MARIO-3 Data Presented at the 2021 San Antonio Breast Cancer Symposium
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
News headline image
Infinity Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update
From Infinity Pharmaceuticals, Inc.
Via Business Wire
Tickers INFI
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.